|
|
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years
Gilles Boschetti
,
Stephane Nancey
,
Fady Daniel
,
Benjamin Pariente
,
Eric Lerebours
,
et al.
Article dans une revue
hal-03553388v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease
Parambir S. Dulai
,
Aurélien Amiot
,
Laurent Peyrin-Biroulet
,
Vipul Jairaith
,
Mélanie Serrero
,
et al.
Article dans une revue
hal-03552288v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort study (CREOLE)
Yoram Bouhnik
,
Franck Carbonnel
,
David Laharie
,
Carmen Stefanescu
,
Xavier Hebuterne
,
et al.
Communication dans un congrès
hal-03553418v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine
David Laharie
,
Arnaud Bourreille
,
Julien Branche
,
Matthieu Allez
,
Yoram Bouhnik
,
et al.
Article dans une revue
hal-03551241v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study
Aurélien Amiot
,
Jean-Charles Grimaud
,
Xavier Treton
,
Jérôme Filippi
,
Benjamin Pariente
,
et al.
11. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2016, Amsterdam, Netherlands
Communication dans un congrès
hal-03553395v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|